CD4 and Alzheimer disease: Our current understanding of CD4+ T cells interaction with the brain during AD suggests that allowing anti-inflammatory CD4+ T cells infiltration while selectively limiting proinflammatory CD4+ T cells could enhance the disease prognosis.